Amisulpride

Chemical formula: C₁₇H₂₇N₃O₄S  Molecular mass: 369.479 g/mol  PubChem compound: 2159

Therapeutic indications

Amisulpride is indicated for:

Acute and chronic schizophrenic disorders

Population group: only adults (18 - 65 years old)

Amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Amisulpride is contraindicated in the following cases:

Renal insufficiency

Renal failure

Pituitary gland prolactinomas

Prolactinoma

Breast cancer

Malignant neoplasm of breast

Phaeochromocytoma

Phaeochromocytoma

Levodopa

Levodopa

Dopamine agonists

at least one of
Amantadine
Apomorphine
Bromocriptine
Cabergoline
Entacapone
Lisuride
Pergolide
Piribedil
Quinagolide
Ropinirole

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: SOLIAN Tablets
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈